We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Brinker International, Vista Outdoor, Brunswick Corp, Fiesta Restaurant and Malibu Boats
Read MoreHide Full Article
For Immediate Release
Chicago, IL – November 18, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Brinker International, Inc. (EAT - Free Report) , Vista Outdoor Inc. (VSTO - Free Report) , Brunswick Corp. (BC - Free Report) , Fiesta Restaurant Group, Inc. and Malibu Boats, Inc. (MBUU - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
5 Value Stocks to Benefit from Positive Vaccine News
Encouraging developments on the COVID-19 vaccine front bodes well for economic growth, and in turn should boost value stocks mostly perceived to be cyclical in nature. These economically-sensitive stocks that have been so far battered by the pandemic can now finally turn around.
When the pandemic forced the United States to go into a lockdown, these stocks, which largely depended on the proper functioning of the economy, took a hit. Businesses and stores were shut and people had to stay at home to avoid the risk of exposure. This led the economy into a downfall wherein all indicators pointed toward a recession.
However, over the past few months, the economy has seen a turnaround. Indicators began to improve with the third-quarter GDP rising substantially. Per the “advance” estimate released by the Bureau of Economic Analysis, real GDP expanded at an annual rate of 33.1% following the dip of 31.4% in the second quarter.
Moreover, the Commerce Department reported that new orders for manufactured goods held up for five consecutive months through September. It rose 1.1% in September following a 0.6% increase in August, as quoted in a Reuters article. Meanwhile, manufacturing activity continued to witness expansion. The manufacturing purchasing manager’s index expanded for the sixth month in a row in October at 59.3%, per the latest release by the Institute of Supply Management.
These positive indicators have been a result of economic activities slowly resuming with both demand and supply returning. So, the promising news with regard to vaccine for COVID-19 will only add strength to this recovery. It will also, in turn, allow value stocks to rebound as demand will increase as a result of consumers being encouraged to spend more.
Coming to vaccine news, on Nov 16, Moderna announced in a press release that their vaccine candidate was found to be 94.5% effective in the first interim analysis of Phase 3. This positive news comes on the heels of Pfizer and BioNTech's announcement of their vaccine’s effectiveness last week. Per a press release issued by the companies on Nov 9, their vaccine candidate was found to be more than 90% effective.
Moreover, Moderna announced in another press release that its vaccine remained stable at “2° to 8°C (36° to 46°F), the temperature of a standard home or medical refrigerator, for 30 days.” It will also remain stable at “-20° C (-4°F) for up to six months.” Such news is promising for the economy as a vaccine will be effective in starting the complete recovery from the pandemic that it needs.
5 Top Value Stock to Buy Now
Positive news related to the vaccine will allow the economy to open up. These will lead to the resumption of activities, which have been hindered by the stay-at-home requirements. Hence, it will be prudent to invest in value stocks which stand to benefit from this development.
Brinker International, through its subsidiaries, owns, develops, operates and franchises casual dining restaurants in the United States. The company currently has a Zacks Rank #1. It also currently has a Value Score B. The Zacks Consensus Estimate for its current-year earnings has moved 33.3% north over the past 60 days. The company’s expected earnings growth rate for the current year is 61.4%.
Vista Outdoor operates through shooting sports and outdoor products segments, and designs, manufactures and markets consumer products for outdoor sports and recreation markets in the United States. The company currently has a Zacks Rank #1. It also currently has a Value Score A. The Zacks Consensus Estimate for its current-year earnings has risen 36.4% over the past 60 days. The company’s expected earnings growth rate for the current year is more than 100%.
Brunswick Corp. designs, manufactures and markets recreation products in the United States. The company currently has a Zacks Rank #2. It also currently has a Value Score B. The Zacks Consensus Estimate for its current-year earnings has climbed 15.1% over the past 60 days. The company’s expected earnings growth rate for the current year is 9%.
Fiesta Restaurant Group, through its subsidiaries, owns, operates and franchises fast-casual restaurants in the United States. The company currently has a Zacks Rank #2. It also currently has a Value Score A. The Zacks Consensus Estimate for its next-year earnings has moved up 85.7% over the past 60 days. The company’s expected earnings growth rate for the next quarter is over 100%.
Malibu Boats designs, manufactures, markets and sells recreational products in the United States. The company currently has a Zacks Rank #2. It also currently has a Value Score B. The Zacks Consensus Estimate for its current-year earnings has risen 10.3% over the past 60 days. The company’s expected earnings growth rate for the current year is 46.8%.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
The Zacks Analyst Blog Highlights: Brinker International, Vista Outdoor, Brunswick Corp, Fiesta Restaurant and Malibu Boats
For Immediate Release
Chicago, IL – November 18, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Brinker International, Inc. (EAT - Free Report) , Vista Outdoor Inc. (VSTO - Free Report) , Brunswick Corp. (BC - Free Report) , Fiesta Restaurant Group, Inc. and Malibu Boats, Inc. (MBUU - Free Report) .
Here are highlights from Tuesday’s Analyst Blog:
5 Value Stocks to Benefit from Positive Vaccine News
Encouraging developments on the COVID-19 vaccine front bodes well for economic growth, and in turn should boost value stocks mostly perceived to be cyclical in nature. These economically-sensitive stocks that have been so far battered by the pandemic can now finally turn around.
When the pandemic forced the United States to go into a lockdown, these stocks, which largely depended on the proper functioning of the economy, took a hit. Businesses and stores were shut and people had to stay at home to avoid the risk of exposure. This led the economy into a downfall wherein all indicators pointed toward a recession.
However, over the past few months, the economy has seen a turnaround. Indicators began to improve with the third-quarter GDP rising substantially. Per the “advance” estimate released by the Bureau of Economic Analysis, real GDP expanded at an annual rate of 33.1% following the dip of 31.4% in the second quarter.
Moreover, the Commerce Department reported that new orders for manufactured goods held up for five consecutive months through September. It rose 1.1% in September following a 0.6% increase in August, as quoted in a Reuters article. Meanwhile, manufacturing activity continued to witness expansion. The manufacturing purchasing manager’s index expanded for the sixth month in a row in October at 59.3%, per the latest release by the Institute of Supply Management.
These positive indicators have been a result of economic activities slowly resuming with both demand and supply returning. So, the promising news with regard to vaccine for COVID-19 will only add strength to this recovery. It will also, in turn, allow value stocks to rebound as demand will increase as a result of consumers being encouraged to spend more.
Coming to vaccine news, on Nov 16, Moderna announced in a press release that their vaccine candidate was found to be 94.5% effective in the first interim analysis of Phase 3. This positive news comes on the heels of Pfizer and BioNTech's announcement of their vaccine’s effectiveness last week. Per a press release issued by the companies on Nov 9, their vaccine candidate was found to be more than 90% effective.
Moreover, Moderna announced in another press release that its vaccine remained stable at “2° to 8°C (36° to 46°F), the temperature of a standard home or medical refrigerator, for 30 days.” It will also remain stable at “-20° C (-4°F) for up to six months.” Such news is promising for the economy as a vaccine will be effective in starting the complete recovery from the pandemic that it needs.
5 Top Value Stock to Buy Now
Positive news related to the vaccine will allow the economy to open up. These will lead to the resumption of activities, which have been hindered by the stay-at-home requirements. Hence, it will be prudent to invest in value stocks which stand to benefit from this development.
Thanks to our style score system, we have been able to identify five value stocks. Our research shows that stocks with a Value Score of A or B when combined with a Zacks Rank #1 (Strong Buy) or 2 (Buy) offer the best opportunities in the value investing space. You can see the complete list of today’s Zacks #1 Rank stocks here.
Brinker International, through its subsidiaries, owns, develops, operates and franchises casual dining restaurants in the United States. The company currently has a Zacks Rank #1. It also currently has a Value Score B. The Zacks Consensus Estimate for its current-year earnings has moved 33.3% north over the past 60 days. The company’s expected earnings growth rate for the current year is 61.4%.
Vista Outdoor operates through shooting sports and outdoor products segments, and designs, manufactures and markets consumer products for outdoor sports and recreation markets in the United States. The company currently has a Zacks Rank #1. It also currently has a Value Score A. The Zacks Consensus Estimate for its current-year earnings has risen 36.4% over the past 60 days. The company’s expected earnings growth rate for the current year is more than 100%.
Brunswick Corp. designs, manufactures and markets recreation products in the United States. The company currently has a Zacks Rank #2. It also currently has a Value Score B. The Zacks Consensus Estimate for its current-year earnings has climbed 15.1% over the past 60 days. The company’s expected earnings growth rate for the current year is 9%.
Fiesta Restaurant Group, through its subsidiaries, owns, operates and franchises fast-casual restaurants in the United States. The company currently has a Zacks Rank #2. It also currently has a Value Score A. The Zacks Consensus Estimate for its next-year earnings has moved up 85.7% over the past 60 days. The company’s expected earnings growth rate for the next quarter is over 100%.
Malibu Boats designs, manufactures, markets and sells recreational products in the United States. The company currently has a Zacks Rank #2. It also currently has a Value Score B. The Zacks Consensus Estimate for its current-year earnings has risen 10.3% over the past 60 days. The company’s expected earnings growth rate for the current year is 46.8%.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Download Marijuana Moneymakers FREE >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.